Furthermore, obesity has also been associated with lower circulating PSA levels and prostatic enlargement, making the detection of existing PCa more difficult.23 Thus, overweight and obese men with a higher GRS should be more actively screened, and hence PCa will be detected more frequently in this cohort. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.